Grifols GRFS
NASDAQ GRFS
$8.84 +0.08 (+0.91%)
At close: Nov 11, 2026 · 4:00 PM EST

Grifols (GRFS) Gains (Losses) on Sale of Assets & Investments (2010 - 2011)

Updated

Grifols (GRFS) posted Gains (Losses) on Sale of Assets & Investments of -$17.44 million for the quarter ended Dec 31, 2011, compared with -$647,753 a year earlier.

Analysis

Grifols (GRFS) Gains (Losses) on Sale of Assets & Investments (2010 - 2011) Analysis & Trends

For the year ended Dec 31, 2011, Grifols' Gains (Losses) on Sale of Assets & Investments came in at -$50.05 million.

  • In prior years, Grifols' Gains (Losses) on Sale of Assets & Investments was -$493,597 in the year ended Dec 31, 2010 and -$1.6 million in the year ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Grifols 5.96 Bn 5.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -17.44 Mn
Sep 30, 2011 -1.01 Mn
Dec 31, 2010 -647,752.86
Sep 30, 2010 -743,773.03
API Access

Grifols Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=GRFS&period=max&api_key=YOUR_API_KEY